title: Infliximab and quality of life in steroid-dependent Crohn's disease.
authors.forename: V
authors.initials: V
authors.lastname: D'Ovidio
authors.forename: A
authors.initials: A
authors.lastname: Aratari
authors.forename: A
authors.initials: A
authors.lastname: Viscido
authors.forename: M T
authors.initials: MT
authors.lastname: Pimpo
authors.forename: R
authors.initials: R
authors.lastname: Caprilli
authors.forename: P
authors.initials: P
authors.lastname: Torchio
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D013256:Steroids / Q000009:adverse effects*; D019966:Substance-Related Disorders
chemical_list: D000911:Antibodies, Monoclonal; D013256:Steroids; D000069285:Infliximab